Clinical Trials · NCT01301222

Role of Octreotide in Preventing Pancreatic Fistula After Pancreaticoduodenectomy (PD) in Patients With Soft Pancreas

CompletedPhase 4Octreotide (Approved)
Phase
Phase 4
Recruitment status
Completed
Sponsor
PVS Memorial Hospital
Enrollment
110
Start date
Sep 2010
Locations
1 site, India
Primary endpoint
Pancreatic fistula
View Octreotide compound reference